Odyssey Health, Inc. (ODYY) stock
ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31
$0.01−0.00 (-16.25%)
Close on Oct 19, 2026Market cap $746.34KP/E –Yield –
Odyssey Health r&d expenses
Research and development expenses are spending on new products and technology.
Odyssey Health's R&D Expenses for the twelve months ending Jul 31, 2025 was $22.63K, down 59.0% year over year. For fiscal 2026 it was $0, down 100.0% from the year before. The highest annual figure on record is $23.01M in fiscal 2019.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $0 | -100.0% |
| FY2025 | Jul 31, 2025 | $22.63K | -59.0% |
| FY2024 | Jul 31, 2024 | $55.17K | -67.5% |
| FY2023 | Jul 31, 2023 | $170.00K | -89.6% |
| FY2021 | Jul 31, 2021 | $1.63M | +7967.4% |
| FY2020 | Jul 31, 2020 | $20.24K | -99.9% |
| FY2019 | Jul 31, 2019 | $23.01M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $22.63K | – |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $0 | – |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $0 | -100.0% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $0 | -100.0% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $0 | – |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $0 | – |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $42.77K | -74.8% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $23.00K | -95.0% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $0 | -100.0% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $0 | -100.0% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $170.00K | -70.0% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $460.72K | +981.0% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | $322.50K | – |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $1.02M | +9905.0% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $565.76K | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $42.62K | – |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | $0 | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $10.24K | – |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | $0 | – |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | $0 | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | $0 | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $0 | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | $0 | – |
See a number that looks wrong?